Pi Pharma Intelligence takes the necessary steps and analysis to provide service reports to identify market access barriers, analyse regulatory and patent trends in the therapy areas and overview all clinical programs around a particular molecule
Recommendation on FTO and access strategy
Pi Pharma intelligence, through its service reports, provide :
”I was impressed at the detailed data that PI pharma is offering for academic and industrial driven research. The reports are very informative and the platform is user-friendly. My research team could optimize our research quality”
”Here we are about to complete our second year of cooperation with our strategic partner “PI”. In fact, they do not stop developing and improving, and I am very excited to try the new version which I expect will be no less perfect than the current version”
Are you wondering about the best market access strategy?
We advise you on sourcing countries and the best model in the market to ensure the earliest commercialization date.
Are you looking for a finished dosage form supplier?
Our platform technology allows us to identify FDF suppliers With their development stage.
Are you looking for API suppliers?
Our platform technology allows you to identify API suppliers who are EU and US DMF-approved.
Do you want to know which therapy area will face the most patent cliffs?
With our database, we can determine when a molecule's basic patent will expire.
Are you curious about clinical updates on specific molecules?
Our clinical reports will analyze each molecule's clinical programs and classify them based on being head-to-head, primary drug and many other features.
Do you want to evaluate the risk in your portfolio?
Our dataset can assess the risks on prices and the number of upcoming generics that can compete with you.
If you're interested in learning more about how our service reports can help you, you can book a demo.